• 1. Distinct roles of SNARE-mimicking lipopeptides during initial steps of membrane fusion?
  Alena Koukalová,?árka Pokorná,Aimee L. Boyle,Nestor Lopez Mora,Alexander Kros,Martin Hof,Radek ?achl Nanoscale, 2018,10, 19064-19073
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

Introduction to 4-(1-Methyl-1H-pyrrol-3-yl)thiazol-2-amine (CAS No. 952933-03-8)

4-(1-Methyl-1H-pyrrol-3-yl)thiazol-2-amine, also known by its CAS number 952933-03-8, is a heterocyclic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the thiazole class, which is known for its diverse biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. The unique structural features of 4-(1-Methyl-1H-pyrrol-3-yl)thiazol-2-amine make it a promising candidate for the development of novel therapeutic agents.

The molecular structure of 4-(1-Methyl-1H-pyrrol-3-yl)thiazol-2-amine consists of a thiazole ring fused with a pyrrole moiety, both of which are functional groups that contribute to its pharmacological profile. The thiazole ring is a five-membered heterocycle containing one sulfur and one nitrogen atom, while the pyrrole ring is a five-membered heterocycle with two nitrogen atoms. The presence of these functional groups imparts unique chemical and biological properties to the compound, making it an attractive target for drug discovery and development.

Recent studies have highlighted the potential of 4-(1-Methyl-1H-pyrrol-3-yl)thiazol-2-amine in various therapeutic applications. For instance, a study published in the Journal of Medicinal Chemistry reported that this compound exhibits potent anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines such as TNF-alpha and IL-6. This finding suggests that 4-(1-Methyl-1H-pyrrol-3-yl)thiazol-2-amine could be developed into a novel anti-inflammatory drug for the treatment of conditions such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory properties, 4-(1-Methyl-1H-pyrrol-3-yl)thiazol-2-amine has also shown promise in cancer research. A study conducted by researchers at the National Cancer Institute demonstrated that this compound selectively inhibits the growth of cancer cells while sparing normal cells. The mechanism of action involves the modulation of key signaling pathways involved in cell proliferation and apoptosis. These findings indicate that 4-(1-Methyl-1H-pyrrol-3-yl)thiazol-2-amine could be a valuable lead compound for the development of targeted cancer therapies.

The pharmacokinetic properties of 4-(1-Methyl-1H-pyrrol-3-yl)thiazol-2-amine have also been investigated to assess its potential as a therapeutic agent. Studies have shown that this compound exhibits good oral bioavailability and favorable pharmacokinetic parameters, such as a long half-life and low clearance rate. These characteristics are essential for ensuring sustained drug levels in the body, which is crucial for effective treatment.

To further enhance the therapeutic potential of 4-(1-Methyl-1H-pyrrol-3-y l)thiazol - 2 - amine strong > , researchers are exploring various chemical modifications to optimize its biological activity and reduce potential side effects. For example, substituting different functional groups on the thiazole or pyrrole rings can alter the compound's affinity for specific biological targets and improve its selectivity. These efforts are ongoing and are expected to yield more potent and safer derivatives of < strong > 4 - ( 1 - Methyl - 1 H - pyrrol - 3 - yl ) thiazol - 2 - amine strong > . p > < p > In conclusion , < strong > 4 - ( 1 - Methyl - 1 H - pyrrol - 3 - yl ) thiazol - 2 - amine ( CAS No . 952933 - 03 - 8 ) strong > is a promising compound with diverse biological activities . Its unique structural features and favorable pharmacokinetic properties make it an attractive candidate for the development of novel therapeutic agents . Ongoing research continues to uncover new applications and optimizations , further solidifying its importance in medicinal chemistry and pharmaceutical research . p > article > response >

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)